On July 16, 2021 CytoImmune Therapeutics, Inc., a clinical-stage immunotherapy company developing a novel class of NK cell-based therapies for cancer, reported that its President, Will Rosellini, will be presenting at the following industry conferences (Press release, CytoImmune Therapeutics, JUL 16, 2021, View Source [SID1234584903]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2nd Annual LifeSci Partners Private Company Summer Symposium
Event Details: Presentation by CytoImmune Therapeutics President William Rosellini, JD, MBA
Date & Time: Wednesday, July 21st at 1.30pm ET

SVB LeeRink Virtual Healthcare Conference
Event Details: Investor Meetings by CytoImmune Therapeutics President William Rosellini
Date & Time: Wednesday, July 21st and Thursday, July 22nd